SAMANTHA DIMEO: Open Payments
NPI 1841840071 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 16 payments from 11 companies in 2025. Trend: 2023 $467 · 2024 $1,011 · 2025 $486
Food & beverage: $311Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $175 |
| ABBVIE INC. | 5 | $91 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Averitas Pharma Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| TG Therapeutics, Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $22 |
| Biogen, Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $19 |
Products named: ULTOMIRIS, UBRELVY, INGREZZA, QUTENZA, Gamunex-C, NURTEC ODT, BRIUMVI, VUMERITY.
Industry payments across OH — which companies pay providers there.
